The Potential of Givinostat as DDI Victim in Co-administration P-gp Inhibitor (Part 2)
Status:
Completed
Trial end date:
2022-05-24
Target enrollment:
Participant gender:
Summary
Primary objective:
To assess the potential effect of oral clarithromycin on the single dose pharmacokinetics of
givinostat.
Secondary objective:
To assess the safety and tolerability of concomitant administration of givinostat plus
clarithromycin.